benefits of low dose semaglutide - Uses | Limitations Exploring beyond numeric weight loss:

[4] [10] Data from a phase 2 trial published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated that gastrointestinal side effects were among the most commonly reported adverse events with retatrutide, particularly at higher doses

Journal of Biomaterials Science

Phase 3: Maintenance (Weeks 912) Dose: 2-3x per week Pulsed administration keeps the repair signal present without turning the protocol into constant stimulation

It requires daily dosing, compared to weekly dosing for semaglutide and tirzepatide

[PMID: 17461586] PubMed record related to this compound for laboratory literature review